Armstrong, A. J., Luo, J., Anand, M., Antonarakis, E. S., Nanus, D. M., Giannakakou, P., … Halabi, S. (2020). AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY.

Armstrong, Andrew J., Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou, Russell Zelig Szmulewitz, et al. “AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38. AMER SOC CLINICAL ONCOLOGY, 2020.

Armstrong AJ, Luo J, Anand M, Antonarakis ES, Nanus DM, Giannakakou P, et al. AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.

Armstrong, Andrew J., et al. “AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 6, AMER SOC CLINICAL ONCOLOGY, 2020.

Armstrong AJ, Luo J, Anand M, Antonarakis ES, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Berry WR, Wenstrup R, Scher HI, Tagawa ST, George DJ, Halabi S. AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.